InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Ellison Mark Jason Heath, Directeur du Développement. Officer active across 1 company, notably Opiant Pharmaceuticals, INC.. Aggregated, 3 disclosures have been published. Activity tracked since 4 January 2022. The latest transaction was filed on 27 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
2,000 shares0Common StockSEC:0001385508-22-000104:0
12,000 shares0Common StockSEC:0001385508-22-000011
12,000 shares0Common StockSEC:0001385508-22-000011:0
3 of 3 declarations
About Ellison Mark Jason Heath
Mark Jason Heath Ellison is the Chief Development Officer at Opiant Pharmaceuticals, Inc. In this role, he is responsible for the business development strategy and growth of the company in the pharmaceutical sector. His expertise in product development and project management is essential for innovation and success at Opiant Pharmaceuticals. Mark Jason Heath Ellison plays a key role in expanding the company's operations.
